To the full analysis
Buyback calculator for Corvus Pharmaceuticals
Corvus Pharmaceuticals stock: key metrics
CRVSCorvus Pharmaceuticals had an operating margin of 0% and a return on invested capital (ROIC) of −71% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2014 | no data | no data | no data |
| 2015 | no data | no data | no data |
| 2016 | no data | no data | no data |
| 2017 | no data | no data | no data |
| 2018 | no data | no data | no data |
| 2019 | no data | no data | no data |
| 2020 | no data | no data | no data |
| 2021 | no data | no data | no data |
| 2022 | no data | no data | no data |
| 2023 | no data | no data | no data |
| 2024 | no data | no data | no data |
| 2025 | no data | no data | no data |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2014 | 110.7% | −1.1% | −1.4% |
| 2015 | 100.8% | −20.2% | −31.8% |
| 2016 | −27.4% | −25.6% | −26.0% |
| 2017 | −65.6% | −41.0% | −58.7% |
| 2018 | −42.5% | −39.8% | −39.7% |
| 2019 | −65.6% | −41.8% | −55.8% |
| 2020 | −8.3% | −46.8% | −7.0% |
| 2021 | −44.5% | −99.2% | −39.5% |
| 2022 | −73.6% | −32.7% | −60.5% |
| 2023 | −69.9% | −38.5% | −59.3% |
| 2024 | −100.0% | −60.3% | −90.4% |
| 2025 | −25.0% | −71.0% | −21.5% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 31 Mar 2017)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.